Wong-Beringer A - Search Results

1

Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.

Wong-Beringer A, Wiener-Kronish J, Lynch S, Flanagan J. Wong-Beringer A, et al. Clin Microbiol Infect. 2008 Apr;14(4):330-6. doi: 10.1111/j.1469-0691.2007.01939.x. Epub 2008 Jan 11. Clin Microbiol Infect. 2008. PMID: 18190571 Free article.

2

Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.

Kriengkauykiat J, Porter E, Lomovskaya O, Wong-Beringer A. Kriengkauykiat J, et al. Antimicrob Agents Chemother. 2005 Feb;49(2):565-70. doi: 10.1128/AAC.49.2.565-570.2005. Antimicrob Agents Chemother. 2005. PMID: 15673734 Free PMC article.

3

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.

Hsu DI, Okamoto MP, Murthy R, Wong-Beringer A. Hsu DI, et al. J Antimicrob Chemother. 2005 Apr;55(4):535-41. doi: 10.1093/jac/dki026. Epub 2005 Feb 22. J Antimicrob Chemother. 2005. PMID: 15728150

4

An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse.

Wong-Beringer A, Nguyen LH, Lee M, Shriner KA, Pallares J. Wong-Beringer A, et al. Pharmacotherapy. 2009 Jun;29(6):736-43. doi: 10.1592/phco.29.6.736. Pharmacotherapy. 2009. PMID: 19476424

5

Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?

Yamaki J, Lee M, Shriner KA, Wong-Beringer A. Yamaki J, et al. Diagn Microbiol Infect Dis. 2011 May;70(1):124-30. doi: 10.1016/j.diagmicrobio.2010.12.003. Epub 2011 Mar 9. Diagn Microbiol Infect Dis. 2011. PMID: 21392923

6

Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.

Agnello M, Wong-Beringer A. Agnello M, et al. PLoS One. 2012;7(8):e42973. doi: 10.1371/journal.pone.0042973. Epub 2012 Aug 8. PLoS One. 2012. PMID: 22905192 Free PMC article.

7

Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.

Sullivan E, Bensman J, Lou M, Agnello M, Shriner K, Wong-Beringer A. Sullivan E, et al. Crit Care Med. 2014 Jan;42(1):48-56. doi: 10.1097/CCM.0b013e318298a86f. Crit Care Med. 2014. PMID: 23963124

8

Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Tai KP, Kamdar K, Yamaki J, Le VV, Tran D, Tran P, Selsted ME, Ouellette AJ, Wong-Beringer A. Tai KP, et al. Innate Immun. 2015 Jan;21(1):17-29. doi: 10.1177/1753425913514784. Epub 2013 Dec 17. Innate Immun. 2015. PMID: 24345876 Free PMC article.

9

The use of oligonucleotide recombination to generate isogenic mutants of clinical isolates of Pseudomonas aeruginosa.

Agnello M, Wong-Beringer A. Agnello M, et al. J Microbiol Methods. 2014 Mar;98:23-5. doi: 10.1016/j.mimet.2013.11.014. Epub 2013 Dec 25. J Microbiol Methods. 2014. PMID: 24374216 Free PMC article.

10

Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.

Beringer PM, Bensman TJ, Ho H, Agnello M, Denovel N, Nguyen A, Wong-Beringer A, She R, Tran DQ, Moskowitz SM, Selsted ME. Beringer PM, et al. J Antimicrob Chemother. 2016 Jan;71(1):181-8. doi: 10.1093/jac/dkv301. Epub 2015 Oct 3. J Antimicrob Chemother. 2016. PMID: 26433781 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters